Semaglutide Market Propelled by the Growing Popularity of Weight Loss Drugs
by Semaglutide is an analog of the glucagon-like peptide-1 (GLP-1) hormone that is used for the treatment of obesity and type 2 diabetes. It mimics the …
Tag: Semaglutide Market Growth
Semaglutide Market Is Expected To Be Flourished By Growing Prevalence Of Obesity And Diabetes
Semaglutide is an injectable GLP-1 receptor agonist drug used for the treatment of obesity and type 2 diabetes. It mimics the actions of the naturally …
The Semaglutide Market Estimated To Witness Strong Growth Due To High Diabetes Incidence And Government Support For Novel Therapies
The Semaglutide market is estimated to be valued at US$ 2.17 Billion in 2022 and is expected to exhibit a CAGR of 8.71% over the …